Skip to main content
Clinical Trials/JPRN-UMIN000004253
JPRN-UMIN000004253
Completed
未知

Comparison of hypotensive effect and prevention to progression of diabetic nephrolopathy with Olmesartan and Ca channel blocker in patient of type 2 diabetic - Saitama Olmesartan Randomised Trial(SORT study)

Endcrinology and Diabetis,Saitama Medical University0 sites150 target enrollmentSeptember 22, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
hypertension with type 2 diabetis
Sponsor
Endcrinology and Diabetis,Saitama Medical University
Enrollment
150
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2010
End Date
September 30, 2013
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Endcrinology and Diabetis,Saitama Medical University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • patient of 1\)RAS inhibitor with Ca channel Blocker 2\)except from 20 to 80 years old 3\)SBP less than 130mmHg or DBP less than 80mmHg 4\)HbA1c over 8\.0% 5\)S\-Cr over 2\.5mg/dL 6\)hypersensitivity to drug in object 7\)inadequate with Doctor's decision

Outcomes

Primary Outcomes

Not specified

Similar Trials